Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Human hair follicle stem cells can turn into multiple cell types but lose some of this ability after being grown in the lab for a long time.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Some breast cancer chemotherapy can cause permanent hair loss.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

The flexible fixed-sequence testing method allows for more effective evaluation of multiple goals in a clinical trial while controlling the risk of false positives.

Finasteride can reduce fertility in some men, but stopping it increases sperm count.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Some medications can cause acne, and stopping these drugs is the main treatment.

Skin grafting is a key procedure for repairing skin defects, with the success depending on the right graft choice, donor site management, and aftercare.

MRL/MpJ mice's skin wounds heal with scars, unlike their ear wounds which can regenerate.

Dupilumab may cause significant hair loss, which can reverse after stopping the drug.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Scientists created a gel with nanoparticles to deliver medicine to hair follicles effectively.

Surface-modified nanoparticles mainly use non-follicular pathways to enhance skin permeation of ibuprofen and could improve treatment for inflammatory skin diseases.

LLLT promotes hair growth and improves hair density safely in men and women.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Intense pulsed light (IPL) is an efficient and safe method for hair removal, reducing hair by about 80%.

Minoxidil causes excessive hair growth in almost all patients.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Hair transplanting is a useful, often overlooked treatment for female pattern hair loss.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Women's hair generally gets thinner and less dense starting in their mid-thirties, with hair loss becoming more common as they age due to both genetics and environment.

Kenogen increases with hair loss in women.

Ephrins slow down skin and hair follicle cell growth.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Accurate clinical, histological, and genetic methods are key for understanding and treating hair disorders.